Source: BioSpace

Merck: MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson's Research

MilliporeSigma and The Michael J. Fox Foundation for Parkinson's Research (MJFF), are advancing research aimed at slowing progression of Parkinson's disease (PD).

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
Matthias Heinzel's photo - CEO of Merck

CEO

Matthias Heinzel

CEO Approval Rating

59/100

Read more